VBI Vaccines Inc. (VBIV)
0.07
0.00 (7.20%)
At close: Aug 07, 2024, 8:00 PM
7.20% (1D)
| Bid | n/a |
| Market Cap | 1.87M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -3.54 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 27,931,464 |
| Avg. Volume (20D) | 8,497,955 |
| Open | 0.09 |
| Previous Close | 0.07 |
| Day's Range | 0.07 - 0.09 |
| 52-Week Range | 0.02 - 1.35 |
| Beta | 2.17 |
About VBIV
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP ...
Industry Biotechnology
Sector Healthcare
IPO Date Apr 26, 2010
Employees 131
Stock Exchange NASDAQ
Ticker Symbol VBIV
Website https://www.vbivaccines.com